Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Palatin Technologies (PTN.US)$ Reuters· just
FDA Confirms Acceptability of Palatin's Remaining Phase 3 Pivotal Clinical Trials for Pl9643 in Dry Eye Disease (Ded)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
5239 Views
Comment
Sign in to post a comment